Compass Therapeutics, Inc. — Investor Relations & Filings
Filings indexed
334
across all filing types
Latest filing
2026-05-05
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
CMPX
Compass Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company that develops proprietary antibody-based therapeutics. The company leverages its proprietary antibody discovery engine and in vitro/in vivo platforms to generate diverse antibody panels. This approach is based on a deep understanding of the tumor microenvironment, aiming to develop product candidates that optimize the immune system's anti-tumor response. The company's mission is to create transformative cancer therapies to improve patient outcomes.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-05-05 | English | |
| 8-K - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-05-05 | English | |
| ARS - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-04-29 | English | |
| DEF 14A - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-04-29 | English | |
| 8-K - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-04-27 | English | |
| 4 - Compass Therapeutics, Inc. (0001738021) (Issuer) | 2026-02-10 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 41364935 | 10-Q - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-05-05 | English | ||
| 41354383 | 8-K - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-05-05 | English | ||
| 38559625 | ARS - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-04-29 | English | ||
| 38554813 | DEF 14A - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-04-29 | English | ||
| 37422431 | 8-K - Compass Therapeutics, Inc. (0001738021) (Filer) | 2026-04-27 | English | ||
| 19423439 | 4 - Compass Therapeutics, Inc. (0001738021) (Issuer) | 2026-02-10 | English | ||
| 13107273 | Director's Dealing 2026 | 2026-01-12 | English | ||
| 13107275 | Regulatory Filings 2026 | 2026-01-08 | English | ||
| 13107278 | FORM 8-K | 2026-01-06 | English | ||
| 13107277 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13107276 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13107279 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13107280 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13107282 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 13107283 | Director's Dealing 2026 | 2026-01-05 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Compass Therapeutics, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/32588/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=32588 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=32588 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=32588 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 32588}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Compass Therapeutics, Inc. (id: 32588)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.